Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

The Effect of Virtual Reality Distraction on Anxiety, Pain, and Satisfaction in Patients Undergoing Cardiac Catheterization in Palestine (VR during Cath)

10. november 2026 opdateret af: Murad Abdalkareem Husen Jkhlab, Arab American University (Palestine)

The Effect of Virtual Reality Distraction on Anxiety, Pain, and Satisfaction in Patients Undergoing Cardiac Catheterization in Palestine: A Randomized Controlled Clinical Trial

This randomized controlled trial evaluated the effect of immersive virtual reality (VR) distraction on procedural anxiety, pain, and patient satisfaction among adult patients undergoing cardiac catheterization.

Patients undergoing cardiac catheterization often experience significant anxiety and pain, which can negatively affect procedural outcomes and overall patient satisfaction. Immersive virtual reality has emerged as a promising non-pharmacological nursing intervention to mitigate procedural distress.

Participants were randomized into two groups: an intervention group receiving immersive VR distraction prior to and during the catheterization procedure, and a control group receiving standard nursing care. Procedural anxiety, pain intensity, and overall satisfaction were assessed using validated measurement instruments to determine the efficacy of the intervention.

Studieoversigt

Detaljeret beskrivelse

Background:

Cardiac catheterization is a widely performed invasive diagnostic and therapeutic procedure. Despite its clinical safety, patients frequently experience high levels of pre-procedural and intra-procedural anxiety and physical pain, which can induce hemodynamic instability and reduce patient satisfaction.

Study Design and Setting:

This study was conducted as a single-center, parallel-group, randomized controlled clinical trial at An-Najah National University Hospital in Nablus, Palestine.

Methods & Procedure:

A total of 92 eligible adult patients scheduled for cardiac catheterization were enrolled and randomly allocated (1:1) to either:

  1. VR Intervention Group: Received immersive virtual reality distraction (using a head-mounted display presenting relaxing virtual environments) delivered before and during the catheterization procedure alongside standard care.
  2. Control Group: Received standard peri-procedural nursing care.

Outcomes & Measurements:

Primary Outcome: Procedural anxiety measured before and after the intervention using a validated anxiety scale. Procedural pain intensity measured via the Numeric Rating Scale (NRS) and overall patient satisfaction assessed post-procedure.

Ethical Considerations:

Ethical approval was granted by the Institutional Review Board at Arab American University (R-2026/A/82/N). All participants provided written informed consent prior to enrollment.

Undersøgelsestype

Interventionel

Tilmelding (Faktiske)

92

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

18 år og ældre (Voksen, Ældre voksen)

Tager imod sunde frivillige

Ingen

Køn, der er berettiget til at studere

Alle

Beskrivelse

Inclusion Criteria:

  • Adults ≥ 18 years undergoing elective diagnostic or interventional cardiac catheterization.
  • Able to understand and provide consent in Arabic.
  • No contraindications to VR (e.g., severe motion sickness, uncontrolled epilepsy).

Exclusion Criteria:

  • Emergency cardiac catheterization.
  • Cognitive impairments that might obstruct participation.
  • Severe visual or auditory impairments incompatible with VR use.
  • History of significant adverse reactions to VR.
  • Previous participation in a VR intervention study related to cardiac procedures
  • A documented history of an anxiety disorder

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Støttende pleje
  • Tildeling: Randomiseret
  • Interventionel model: Parallel tildeling
  • Maskning: Ingen (Åben etiket)

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Aktiv komparator: Control Group

Patients in this group received standard peri-procedural nursing and medical care before the cardiac catheterization procedure without virtual reality distraction.

Standard clinical and nursing care during cardiac catheterization without virtual reality intervention.

Eksperimentel: VR Intervention Group

VR Intervention Group patients in this group received immersive virtual reality (VR) distraction using a head-mounted display presenting relaxing virtual environments before the cardiac catheterization procedure, alongside standard care.

Experimental VR Intervention Group Patients in this group received immersive virtual reality (VR) distraction using a head-mounted display presenting relaxing virtual environments before the cardiac catheterization procedure, alongside standard care.

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
State Anxiety Measured by the State-Trait Anxiety Inventory, State Anxiety Subscale (Form Y-1)
Tidsramme: Baseline (on admission, before group allocation), pre-procedure (30 to 60 minutes before cardiac catheterization), and post-procedure (within 30 minutes after completion of cardiac catheterization)

State anxiety was measured using the Arabic version of the State-Trait Anxiety Inventory, State Anxiety Subscale (Form Y-1), a 20-item self-report questionnaire. Total scores range from 20 (minimum) to 80 (maximum); higher scores indicate greater anxiety (a worse outcome). The between-group difference in change from baseline was assessed at the pre-procedural assessment (immediately after the 15-minute virtual reality session in the intervention group, or after an equivalent routine waiting period in the control group) and at the post-procedural assessment.

Baseline (on admission, before group allocation), pre-procedure (30 to 60 minutes before cardiac catheterization), and post-procedure (within 30 minutes after completion of cardiac catheterization)
Pain Intensity Measured by the Numeric Rating Scale
Tidsramme: Baseline (on admission, before group allocation), pre-procedure (30 to 60 minutes before cardiac catheterization), and post-procedure (within 30 minutes after completion of cardiac catheterization)

Pain intensity was measured using an 11-point Numeric Rating Scale. Scores range from 0 (no pain, minimum) to 10 (worst possible pain, maximum); higher scores indicate greater pain intensity (a worse outcome).

Baseline (on admission, before group allocation), pre-procedure (30 to 60 minutes before cardiac catheterization), and post-procedure (within 30 minutes after completion of cardiac catheterization)
Satisfaction With Nursing Care Measured by the Patient Satisfaction With Nursing Care Quality Questionnaire
Tidsramme: Baseline (on admission, before group allocation), pre-procedure (30 to 60 minutes before cardiac catheterization), and post-procedure (within 30 minutes after completion of cardiac catheterization)

Satisfaction with nursing care was measured using the Arabic version of the Patient Satisfaction With Nursing Care Quality Questionnaire. Each of the 17 items is rated from 1 (poor) to 5 (excellent), and the score is the mean of the items, ranging from 1 (minimum) to 5 (maximum); higher scores indicate greater satisfaction (a better outcome).

Baseline (on admission, before group allocation), pre-procedure (30 to 60 minutes before cardiac catheterization), and post-procedure (within 30 minutes after completion of cardiac catheterization)

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Faktiske)

1. september 2026

Primær færdiggørelse (Faktiske)

20. oktober 2026

Studieafslutning (Faktiske)

20. oktober 2026

Datoer for studieregistrering

Først indsendt

6. november 2026

Først indsendt, der opfyldte QC-kriterier

10. november 2026

Først opslået (Faktiske)

13. november 2026

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

13. november 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

10. november 2026

Sidst verificeret

1. november 2026

Mere information

Begreber relateret til denne undersøgelse

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

INGEN

IPD-planbeskrivelse

Individual participant data will not be publicly shared to protect patient privacy and confidentiality in accordance with the institutional review board approvals and informed consent agreements.

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Abonner